Figure . Distribution of patients with clinically diagnosed FH by genotype.
The figure describes the distribution of patients with clinically diagnosed FH according to the results of the genetic test (FH/M+: 54.87% of the sample; FH/M−: 45.13%), and based on the presence of a causative variant, polygenic score, or lp(a) genotype. FH/M− indicates negative familial hypercholesterolemia genetic test; FH/ M+, positive familial hypercholesterolemia genetic test; and lp(a), lipoprotein A.